What question did this study set out to answer?

This research evaluates the differences in neonatal and obstetric outcomes between diet and insulin treatments for gestational diabetes.

Birth Parameters, Neonatal and Obstetric Outcomes of Mothers With Gestational Diabetes Treated With Diet and Insulin: A Retrospective Study

View Full Paper

Ask AI

Bookmark

This research evaluates the differences in neonatal and obstetric outcomes between diet and insulin treatments for gestational diabetes.
Retrospective analysis of neonatal outcomes from 4188 women and obstetric outcomes from 2356 women.
Participants were categorized into diet-only and insulin-treated groups.
Statistical comparisons were made for outcomes between the two treatment groups.
Insulin treatment showed higher rates of large for gestational age (LGA) neonates at 17% compared to 10% in the diet group.
Higher rates of neonatal hypoglycaemia were observed in the insulin group (18% vs. 14%).
Positive predictors for insulin treatment included increased birth weight, head circumference, and length.
Gestational age was decreased in the insulin group, averaging 39.0 weeks compared to 38.6 weeks.

No takes yet. Share an insight, caveat, or question.

Retrospective Study Evaluates Neonatal and Obstetric Outcomes in Mothers With Gestational Diabetes, Indicating Treatment Differences.

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark